Cargando…

Serum p53 antibodies: predictors of survival in small-cell lung cancer?

Serum p53 antibodies have been shown to be a poor prognostic marker in resected non-small-cell lung cancer (NSCLC), but studies in small-cell lung cancer (SCLC) have been contradictory. We have studied the incidence of p53 antibodies in a large SCLC cohort treated at one oncology centre and correlat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Murray, P V, Soussi, T, O'Brien, M E R, Smith, I E, Brossault, S, Norton, A, Ashley, S, Tavassoli, M
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2000
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363416/ https://www.ncbi.nlm.nih.gov/pubmed/11076647 http://dx.doi.org/10.1054/bjoc.2000.1475

Ejemplares similares

p53 protein, EGF receptor, and anti-p53 antibodies in serum from patients with occupationally derived lung cancer
por: Schneider, J, et al.
Publicado: (1999)

Pre-operative chemotherapy in early stage resectable non-small-cell lung cancer: a randomized feasibility study justifying a multicentre phase III trial
por: Boer, R H de, et al.
Publicado: (1999)

Detection of p73 antibodies in patients with various types of cancer: immunological characterization
por: Tominaga, O, et al.
Publicado: (2001)

Serum antibodies against p53 in relation to cancer risk and prognosis in breast cancer: a population-based epidemiological study
por: Lenner, P, et al.
Publicado: (1999)

Divergence between the high rate of p53 mutations in skin carcinomas and the low prevalence of anti-p53 antibodies
por: Moch, C, et al.
Publicado: (2001)

Serum anti-p53 antibodies in gastric adenocarcinoma patients are associated with poor prognosis, lymph node metastasis and poorly differentiated nuclear grade
por: Wu, C-W, et al.
Publicado: (1999)

Psychosocial predictors of outcome: time to relapse and survival in patients with early stage melanoma
por: Brown, J E, et al.
Publicado: (2000)

Clinical significance of circulating anti-p53 antibodies in European patients with hepatocellular carcinoma
por: Saffroy, R, et al.
Publicado: (1999)

Prospective study of intratumoral microvessel density, p53 expression and survival in colorectal cancer
por: Vermeulen, P B, et al.
Publicado: (1999)

Hypoxia in human soft tissue sarcomas: Adverse impact on survival and no association with p53 mutations
por: Nordsmark, M, et al.
Publicado: (2001)

Analyses of p53 antibodies in sera of patients with lung carcinoma define immunodominant regions in the p53 protein.
por: Schlichtholz, B., et al.
Publicado: (1994)

The effect of tamoxifen and cisplatin on the disease-free and overall survival of patients with high risk malignant melanoma
por: McClay, E F, et al.
Publicado: (2000)

Autoimmunity against p53 predicts invasive cancer with poor survival in patients with an ovarian mass
por: Vogl, F D, et al.
Publicado: (2000)

Combined RAF1 protein expression and p53 mutational status provides a strong predictor of cellular radiosensitivity
por: Warenius, H M, et al.
Publicado: (2000)

Serum p53 autoantibodies in patients with minimal lesions of ductal carcinoma in situ of the breast
por: Regele, S, et al.
Publicado: (1999)

Evaluation of VIDAS(®) Diagnostic Assay Prototypes Detecting Dengue Virus NS1 Antigen and Anti-Dengue Virus IgM and IgG Antibodies
por: Somlor, Somphavanh, et al.
Publicado: (2021)

A randomized phase II study of SRL172 (Mycobacterium vaccae) combined with chemotherapy in patients with advanced inoperable non-small-cell lung cancer and mesothelioma
por: O’Brien, M E R, et al.
Publicado: (2000)

Serum lactate dehydrogenase predicts survival in small-cell lung cancer patients with brain metastases that were treated with whole-brain radiotherapy
por: Anami, Shimpei, et al.
Publicado: (2019)

TP53: an oncogene in disguise
por: Soussi, T, et al.
Publicado: (2015)

Apoptosis and p53 status predict the efficacy of postoperative administration of UFT in non-small cell lung cancer
por: Tanaka, F, et al.
Publicado: (2001)

Extracellular Matrix Survival Signals Transduced by Focal Adhesion Kinase Suppress p53-mediated Apoptosis
por: Ilić, Duško, et al.
Publicado: (1998)

Expression of apoptosis regulatory proteins of the Bcl-2 family and p53 in primary resected non-small-cell lung cancer
por: Borner, M M, et al.
Publicado: (1999)

Carbonyl reductase as a significant predictor of survival and lymph node metastasis in epithelial ovarian cancer
por: Umemoto, M, et al.
Publicado: (2001)

Time and chemotherapy treatment trends in the treatment of elderly patients (age ⩾70 years) with small cell lung cancer
por: Yau, T, et al.
Publicado: (2006)

Medulla oblongata volume as a promising predictor of survival in amyotrophic lateral sclerosis
por: Milella, Giammarco, et al.
Publicado: (2022)

p21(WAF1/CIP1)expression in stage I cutaneous malignant melanoma: its relationship with p53, cell proliferation and survival
por: Karjalainen, J M, et al.
Publicado: (1999)

Anti-Her-2/neu antibody induces apoptosis in Her-2/neu overexpressing breast cancer cells independently from p53 status
por: Brodowicz, T, et al.
Publicado: (2001)

Activation and activities of the p53 tumour suppressor protein
por: Bálint, É, et al.
Publicado: (2001)

Large-scale UK audit of blood transfusion requirements and anaemia in patients receiving cytotoxic chemotherapy
por: Barrett-Lee, P J, et al.
Publicado: (2000)

Serum Protein Profiling of Systemic Lupus Erythematosus and Systemic Sclerosis Using Recombinant Antibody Microarrays
por: Carlsson, Anders, et al.
Publicado: (2011)

Protein array processing software for automated semiquantitative analysis of serum antibody repertoires
por: Yadav, Ajeet Singh, et al.
Publicado: (2023)

ATM protein and p53-serine 15 phosphorylation in ataxia-telangiectasia (AT) patients and at heterozygotes
por: Delia, D, et al.
Publicado: (2000)

Genomic alterations associated with loss of heterozygosity for TP53 in Li-Fraumeni syndrome fibroblasts
por: Burt, E C, et al.
Publicado: (2000)

Relevance of proliferative and pro-apoptotic factors in non-small-cell lung cancer for patient survival
por: Volm, M, et al.
Publicado: (2000)

The significance of p53 codon 72 polymorphism for the development of cervical adenocarcinomas
por: Andersson, S, et al.
Publicado: (2001)

p53 status of newly established acute myeloid leukaemia cell lines
por: Zheng, A, et al.
Publicado: (1999)

Expression of high p53 levels in colorectal cancer: a favourable prognostic factor
por: Adrover, E, et al.
Publicado: (1999)

The value of rapid functional assays of germline p53 status in LFS and LFL families
por: Camplejohn, R S, et al.
Publicado: (2000)

Enhanced prediction of breast cancer prognosis by evaluating expression of p53 and prostate-specific antigen in combination
por: Yu, H, et al.
Publicado: (1999)

Mathematical and experimental analysis of localization of anti-tumour antibody–enzyme conjugates
por: Jackson, T L, et al.
Publicado: (1999)

Cannot write session to /tmp/vufind_sessions/sess_1gsd6o3r5kv59g7vo8ara33005